Clinical trials with REACT® have shown promising early efficacy and safety results. Individuals with Stage 3 and 4 type 2 diabetic CKD are target populations for restoration and stabilization of renal ...
WINSTON-SALEM, N.C., April 12, 2022 (GLOBE NEWSWIRE) -- ProKidney LP ("ProKidney"), a leading clinical-stage cellular therapeutics company focused on therapies for chronic kidney disease ("CKD"), ...
WINSTON-SALEM, N.C., June 23, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease (CKD) and the ...
ROCKFORD — Rockford Health System officials, still grieving the loss of three medical flight crew members who died in a helicopter crash Monday night, are researching how to best bring the flight ...
While the start of a new school year can mean sharpened pencils and fresh crayons for many students, it means visits from the University’s Reaching and Educating America’s Chemists of Tomorrow (REACT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results